Case Study: Building regulatory leadership during acquisition
In 2025, a 23 person MedTech company based in Germany found itself at a pivotal moment.
The business had built an advanced AI powered platform designed to improve the planning of minimally invasive cardiac procedures. By combining medical imaging, decision support and rapid eligibility checks, the technology enabled physicians to work with greater precision and efficiency. With CE marking and FDA clearance already secured, the company had proven both its innovation and its regulatory credibility.
Then came the next chapter.
In October 2025, the organisation was acquired, marking a major milestone in its growth journey. The acquisition opened the door to global deployment and significant scale. It also brought increased scrutiny, integration complexity and heightened regulatory expectations.
An organisation at a turning point
Prior to acquisition, the company had successfully navigated the demanding regulatory landscape of both the EU and US markets. However, operating as part of a global MedTech leader required a different level of structure, oversight and strategic planning.
The organisation needed a Head of Quality and Regulatory Affairs who could:
- Oversee EU and US registrations across all product lines
- Lead regulatory strategy under EU MDR and FDA frameworks
- Strengthen and scale the Quality Management System
- Act as the primary contact for regulatory and notified bodies
- Guide internal teams through audits and inspections
- Provide calm, confident leadership during integration
This was not simply a technical hire. It was a business-critical appointment.
The timeline was tight. The search ran from August to December 2025, during an active acquisition phase. Any delay risked slowing integration milestones, creating regulatory bottlenecks or increasing audit exposure.
Defining the right profile
From our first conversations with the leadership team, it was clear that technical expertise alone would not be enough.
The ideal individual needed to balance strategic thinking with hands-on delivery. They would inherit responsibility for EU MDR, FDA submissions and ISO compliance, while also mentoring the team and embedding stronger systems for long term scale.
We conducted a detailed needs analysis to understand:
- The cultural shift following acquisition
- The maturity of the existing QMS
- Reporting lines within the new structure
- The level of autonomy expected in the role
- The importance of onsite presence within a collaborative, innovation led environment
A targeted and discreet search
Given the specialist nature of the requirement, we implemented a focused headhunting strategy across Germany and key MedTech hubs.
We began with a detailed consultation process, mapping the technical, cultural and strategic requirements of the role. Understanding the post-acquisition context was essential.
Over the course of 23 weeks:
- 140 candidates were sourced and mapped
- 10 candidates were shortlisted following detailed screening
- 5 candidates progressed to formal interview
Each shortlisted candidate was assessed against EU MDR and FDA expertise, ISO knowledge, PRRC experience, QMS implementation capability and leadership maturity.
Beyond technical capability, we examined mindset. The business required resilience, adaptability and the ability to lead through change.
Maintaining momentum during an acquisition is never straightforward. Through structured interview stages, consistent feedback loops and close collaboration with the leadership team, we ensured progress remained steady despite competing internal priorities.
The result was a carefully considered appointment rather than a rushed decision.
Throughout the process, we maintained close alignment with the client’s leadership team, ensuring swift feedback and structured interviews that balanced technical assessment with cultural fit.
The appointment
By December 2025, the company had secured its new Head of Quality and Regulatory Affairs.
The appointed candidate brought over five years of experience within the medical device industry, covering both software and hardware products. With a Master’s degree in Biomedical Engineering, they had progressed from Regulatory Affairs Specialist and Quality Manager to Quality Management Representative, PRRC and Head of QM and RA.
Technically strong and deeply committed to regulatory excellence, they combined practical submission experience with leadership maturity. Their understanding of mechanical engineering principles applied to the human body, alongside interest in nanotechnologies and biomaterials, aligned closely with the company’s innovation driven culture.
Crucially, they were motivated to work onsite and excited by the opportunity to lead by example, strengthen systems and continue developing within the QM and RA environment.
The impact
The appointment delivered immediate stability during a period of significant change. The newly hired Head of Quality and Regulatory Affairs ensured continuity of compliance across both EU and US markets, reinforced audit readiness and established a clear regulatory strategy aligned with the company’s post acquisition objectives.
Since joining, the leader has played a pivotal role in securing two FDA clearances, further strengthening the company’s regulatory position and supporting the continued advancement of its technology. Their work has also contributed to the organisation’s successful progression toward acquisition by a well known multinational medical device company.
Internally, cross functional collaboration improved, with stronger integration between regulatory, R&D and clinical teams. Externally, the business entered its next phase with greater confidence in its quality governance framework and its ability to scale within a global MedTech environment.
Conclusion
This search was more than a recruitment assignment. It was about safeguarding regulatory integrity at a defining moment in the company’s growth.
By securing the right leader within a compressed timeframe, the organisation was able to move forward into its acquisition phase with confidence, structure and strategic clarity.
Meet the consultant
If your organisation is looking to strengthen its regulatory or quality leadership, reach out to Taylor to discuss how Aspire Life Sciences can support your hiring needs.
Taylor Lyons is a specialist MedTech recruitment consultant at Aspire Life Sciences, focused on supporting innovative medical device and health technology companies as they scale. He partners with organisations across Europe to identify and secure senior talent in regulatory affairs, quality assurance and technical leadership roles. With a strong understanding of the complex regulatory landscape across EU MDR and FDA frameworks, Taylor works closely with clients to deliver candidates who can strengthen compliance, support product approvals and enable sustainable growth. His consultative approach and deep network within the MedTech sector allow him to connect exceptional professionals with companies developing technologies that improve patient outcomes worldwide.
Leave a Reply